These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 19674050)

  • 21. Review and update of the Hong Kong Epilepsy Guideline on status epilepticus.
    Fung EL; Fung BB;
    Hong Kong Med J; 2017 Feb; 23(1):67-73. PubMed ID: 28057897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful management of refractory neonatal seizures with midazolam.
    Sirsi D; Nangia S; LaMothe J; Kosofsky BE; Solomon GE
    J Child Neurol; 2008 Jun; 23(6):706-9. PubMed ID: 18539997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of lacosamide in refractory status epilepticus.
    Goodwin H; Hinson HE; Shermock KM; Karanjia N; Lewin JJ
    Neurocrit Care; 2011 Jun; 14(3):348-53. PubMed ID: 21249530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonconvulsive status epilepticus on treatment with levetiracetam.
    Atefy R; Tettenborn B
    Epilepsy Behav; 2005 Jun; 6(4):613-6. PubMed ID: 15876554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome.
    Koul R; Chacko A; Javed H; Al Riyami K
    J Child Neurol; 2002 Dec; 17(12):908-10. PubMed ID: 12593465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous lacosamide for treatment of status epilepticus.
    Kellinghaus C; Berning S; Immisch I; Larch J; Rosenow F; Rossetti AO; Tilz C; Trinka E
    Acta Neurol Scand; 2011 Feb; 123(2):137-41. PubMed ID: 20868429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.
    Eue S; Grumbt M; Müller M; Schulze A
    Epilepsy Behav; 2009 Aug; 15(4):467-9. PubMed ID: 19616482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: a proof-of-concept, observational study.
    Belcastro V; Vidale S; Pierguidi L; Sironi L; Tancredi L; Striano P; Taborelli A; Arnaboldi M
    Seizure; 2013 Dec; 22(10):905-7. PubMed ID: 23953988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous levetiracetam treatment in status epilepticus: A prospective study.
    Atmaca MM; Orhan EK; Bebek N; Gurses C
    Epilepsy Res; 2015 Aug; 114():13-22. PubMed ID: 26088881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levetiracetam in nonconvulsive status epilepticus in childhood: a case report.
    Trabacca A; Profice P; Costanza MC; Gesualdi M; De Rinaldis M
    J Child Neurol; 2007 May; 22(5):639-41. PubMed ID: 17690075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lacosamide: new drug. Refractory partial epilepsy: optimise existing combinations.
    Prescrire Int; 2009 Oct; 18(103):196. PubMed ID: 19882781
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus.
    Treiman DM; Walker MC
    Epilepsy Res; 2006 Jan; 68 Suppl 1():S77-82. PubMed ID: 16384688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous sodium valproate in mainland China for the treatment of diazepam refractory convulsive status epilepticus.
    Chen L; Feng P; Wang J; Liu L; Zhou D
    J Clin Neurosci; 2009 Apr; 16(4):524-6. PubMed ID: 19243950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical findings, treatment, and outcome of dogs with status epilepticus or cluster seizures: 156 cases (1990-1995).
    Bateman SW; Parent JM
    J Am Vet Med Assoc; 1999 Nov; 215(10):1463-8. PubMed ID: 10579043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
    Uges JW; van Huizen MD; Engelsman J; Wilms EB; Touw DJ; Peeters E; Vecht CJ
    Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lacosamide--oral administration (Vimpat) ].
    Duh D; Peeters S
    J Pharm Belg; 2011 Mar; (1):25-6. PubMed ID: 21473129
    [No Abstract]   [Full Text] [Related]  

  • 38. The anti-epileptic drug lacosamide (Vimpat) has anxiolytic property in rodents.
    Higgins GA; Breysse N; Undzys E; Kuo C; Joharchi N; Derksen DR; Xin T; Isaac M; Slassi M
    Eur J Pharmacol; 2009 Dec; 624(1-3):1-9. PubMed ID: 19818346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comment: lacosamide for the treatment of refractory status epilepticus.
    Trinka E; Höfler J; Tilz C; Kellinghaus C
    Ann Pharmacother; 2012 May; 46(5):765-6; authors reply 766-7. PubMed ID: 22570435
    [No Abstract]   [Full Text] [Related]  

  • 40. Challenges in the treatment of convulsive status epilepticus.
    Zaccara G; Giannasi G; Oggioni R; Rosati E; Tramacere L; Palumbo P;
    Seizure; 2017 Apr; 47():17-24. PubMed ID: 28282553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.